Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Industry	1.96B	2.12B	2.10B	1.87B	-
Commodity Circulation (Commercial)	49.90M	41.25M	46.19M	48.85M	43.87M
Other Business	31.37M	31.75M	27.41M	42.15M	18.38M
Chinese Patent Medicine (Industry)	-	-	-	-	1.59B
Other (Industrial)	-	-	-	-	88.19M
Total	2.05B	2.19B	2.17B	1.96B	1.74B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	2.02B	2.18B	2.16B	1.95B	1.73B
Overseas	28.87M	11.84M	12.35M	11.12M	9.45M
Total	2.05B	2.19B	2.17B	1.96B	1.74B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error